Lastest Insider Transactions Of Evelo Biosciences, Inc. ( EVLO ) |
Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
EVLO | Evelo Biosciences, Inc. | Bodmer Mark | CSO, President of R&D | 2023-11-07 | Sell | 3,163 | 0.33 | 1,044 | 2023-11-08 20:32:53 |
EVLO | Evelo Biosciences, Inc. | Bodmer Mark | CSO, President of R&D | 2023-11-07 | Option Exercise | 6,625 | 0.00 | 0 | 2023-11-08 20:32:53 |
EVLO | Evelo Biosciences, Inc. | McHale Duncan | Chief Medical Officer | 2023-11-07 | Sell | 3,103 | 0.33 | 1,024 | 2023-11-08 20:32:28 |
EVLO | Evelo Biosciences, Inc. | McHale Duncan | Chief Medical Officer | 2023-11-07 | Option Exercise | 6,500 | 0.00 | 0 | 2023-11-08 20:32:28 |
EVLO | Evelo Biosciences, Inc. | GILL SIMBA | President & CEO | 2023-11-07 | Sell | 172 | 0.33 | 57 | 2023-11-08 20:31:56 |
EVLO | Evelo Biosciences, Inc. | GILL SIMBA | President & CEO | 2023-11-07 | Option Exercise | 1,172 | 0.00 | 0 | 2023-11-08 20:31:56 |
EVLO | Evelo Biosciences, Inc. | Thorell Marella | Chief Financial Officer | 2023-11-07 | Sell | 1,811 | 0.33 | 598 | 2023-11-08 20:31:37 |
EVLO | Evelo Biosciences, Inc. | Thorell Marella | Chief Financial Officer | 2023-11-07 | Option Exercise | 6,500 | 0.00 | 0 | 2023-11-08 20:31:37 |
EVLO | Evelo Biosciences, Inc. | Bodmer Mark | CSO, President of R&D | 2023-11-01 | Sell | 6,854 | 0.33 | 2,262 | 2023-11-03 16:12:23 |
EVLO | Evelo Biosciences, Inc. | Bodmer Mark | CSO, President of R&D | 2023-11-01 | Option Exercise | 12,500 | 0.00 | 0 | 2023-11-03 16:12:23 |
EVLO | Evelo Biosciences, Inc. | McHale Duncan | Chief Medical Officer | 2023-11-01 | Sell | 6,854 | 0.33 | 2,262 | 2023-11-03 16:11:35 |
EVLO | Evelo Biosciences, Inc. | McHale Duncan | Chief Medical Officer | 2023-11-01 | Option Exercise | 12,500 | 0.00 | 0 | 2023-11-03 16:11:35 |
EVLO | Evelo Biosciences, Inc. | Thorell Marella | Chief Financial Officer | 2023-11-01 | Sell | 3,999 | 0.33 | 1,320 | 2023-11-03 16:11:13 |
EVLO | Evelo Biosciences, Inc. | Thorell Marella | Chief Financial Officer | 2023-11-01 | Option Exercise | 12,500 | 0.00 | 0 | 2023-11-03 16:11:13 |
EVLO | Evelo Biosciences, Inc. | GILL SIMBA | President & CEO | 2023-09-27 | Sell | 1,996 | 3.94 | 7,864 | 2023-09-29 16:02:17 |
EVLO | Evelo Biosciences, Inc. | GILL SIMBA | President & CEO | 2023-09-27 | Option Exercise | 15,000 | 0.00 | 0 | 2023-09-29 16:02:17 |
EVLO | Evelo Biosciences, Inc. | Bodmer Mark | CSO, President of R&D | 2023-08-07 | Sell | 3,128 | 9.51 | 29,747 | 2023-08-09 20:44:04 |
EVLO | Evelo Biosciences, Inc. | Bodmer Mark | CSO, President of R&D | 2023-08-07 | Option Exercise | 6,625 | 0.00 | 0 | 2023-08-09 20:44:04 |
EVLO | Evelo Biosciences, Inc. | GILL SIMBA | President & CEO | 2023-08-07 | Sell | 342 | 9.51 | 3,252 | 2023-08-09 20:43:24 |
EVLO | Evelo Biosciences, Inc. | GILL SIMBA | President & CEO | 2023-08-07 | Option Exercise | 1,171 | 0.00 | 0 | 2023-08-09 20:43:24 |
EVLO | Evelo Biosciences, Inc. | McHale Duncan | Chief Medical Officer | 2023-08-07 | Sell | 3,434 | 9.51 | 32,657 | 2023-08-09 20:42:39 |
EVLO | Evelo Biosciences, Inc. | McHale Duncan | Chief Medical Officer | 2023-08-07 | Option Exercise | 6,500 | 0.00 | 0 | 2023-08-09 20:42:39 |
EVLO | Evelo Biosciences, Inc. | Thorell Marella | Chief Financial Officer | 2023-08-07 | Sell | 2,004 | 9.51 | 19,058 | 2023-08-09 20:42:02 |
EVLO | Evelo Biosciences, Inc. | Thorell Marella | Chief Financial Officer | 2023-08-07 | Option Exercise | 6,500 | 0.00 | 0 | 2023-08-09 20:42:02 |
EVLO | Evelo Biosciences, Inc. | Flagship Ventures Fund IV General Partner LLC | 10% Owner | 2023-07-11 | Buy | 5,411,255 | 2.31 | 12,499,999 | 2023-07-13 17:15:30 |
EVLO | Evelo Biosciences, Inc. | Bodmer Mark | CSO, President of R&D | 2023-05-23 | Sell | 22,571 | 0.14 | 3,201 | 2023-06-12 16:01:09 |
EVLO | Evelo Biosciences, Inc. | McHale Duncan | Chief Medical Officer | 2023-05-08 | Sell | 66,730 | 0.13 | 8,375 | 2023-05-10 21:32:10 |
EVLO | Evelo Biosciences, Inc. | Bodmer Mark | CSO, President of R&D | 2023-05-08 | Sell | 68,014 | 0.13 | 8,536 | 2023-05-10 21:31:52 |
EVLO | Evelo Biosciences, Inc. | Thorell Marella | Chief Financial Officer | 2023-05-08 | Sell | 38,531 | 0.13 | 4,836 | 2023-05-10 21:31:35 |
EVLO | Evelo Biosciences, Inc. | GILL SIMBA | President & CEO | 2023-05-08 | Sell | 3,537 | 0.13 | 444 | 2023-05-10 21:31:15 |
EVLO | Evelo Biosciences, Inc. | Thorell Marella | Chief Financial Officer | 2023-05-07 | Option Exercise | 130,000 | 0.00 | 0 | 2023-05-09 16:09:37 |
EVLO | Evelo Biosciences, Inc. | GILL SIMBA | President & CEO | 2023-05-07 | Option Exercise | 23,437 | 0.00 | 0 | 2023-05-09 16:09:17 |
EVLO | Evelo Biosciences, Inc. | Bodmer Mark | CSO, President of R&D | 2023-05-07 | Option Exercise | 132,500 | 0.00 | 0 | 2023-05-09 16:08:53 |
EVLO | Evelo Biosciences, Inc. | McHale Duncan | Chief Medical Officer | 2023-05-07 | Option Exercise | 130,000 | 0.00 | 0 | 2023-05-09 16:08:35 |
EVLO | Evelo Biosciences, Inc. | CARRIERE STEPHEN J | Principal Accounting Officer | 2023-01-19 | Sell | 151 | 1.06 | 160 | 2023-01-23 17:35:06 |
EVLO | Evelo Biosciences, Inc. | CARRIERE STEPHEN J | Principal Accounting Officer | 2023-01-19 | Option Exercise | 354 | 0.00 | 0 | 2023-01-23 17:35:06 |